Recent developments in therapeutic applications of atomic and nuclear radiations
by Azam Niroomand-Rad, Colin Orton
Atoms for Peace: an International Journal (AFP), Vol. 1, No. 2/3, 2006

Abstract: In recent years, the major 'challenge' of radiation treatment is to deliver large enough doses to the most resistant cancer cells to provide a high probability of local control while minimising the dose to normal tissues and hence reducing complications. With recent developments in 'imaging' the metabolic or functional status of cancers, the position of tumours relative to surrounding normal tissue can be more clearly delineated. The therapeutic dosage of radiation to the tumours can be escalated without exceeding normal tissue tolerances. These special techniques include: 3D 'conformal' radiation treatment where the shape of the high dose region 'conforms' to the shape of the tumour ('target'), intensity modulated radiation therapy (IMRT) that uses combinations of radiation beams with varying spatial intensity across the fields ('intensity modulated') in order to achieve an 'ideal' dose distribution, image guided radiation treatment, and heavy charged particle radiotherapy.

Online publication date: Sat, 15-Jul-2006

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the Atoms for Peace: an International Journal (AFP):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com